Validation of a Novel Method for Determining the Renal Threshold for Glucose Excretion in Untreated and Canagliflozin-treated Subjects With Type 2 Diabetes Mellitus
Clinical Trials Thursday, April 18th, 2013JCEM: April 12, 2013
Context: The stepwise hyperglycemic clamp procedure (SHCP) is the gold standard for measuring the renal threshold for glucose excretion (RTG), but its use is limited to small studies in specialized laboratories.
Objective: The objective of the study was to validate a new method for determining RTG using data obtained during a mixed-meal tolerance test (MMTT) in untreated and canagliflozin-treated subjects with type 2 diabetes mellitus (T2DM).
Design: This was an open-label study with 2 sequential parts.
Setting: The study was performed at a single center in Germany.
Patients: Twenty-eight subjects with T2DM were studied. Read more